May 11 (Reuters) - Knight Therapeutics
* Bought deal agreement pursuant to which underwriters
agreed to purchase 25 million shares of company at $8.00 per
common share
* Knight therapeutics enters into agreement for a $200
million bought deal of common shares
Source text for Eikon: ID:nCCNbhTXMt
Further company coverage: GUD.TO
(Bengaluru Newsroom: +1-646-223-8780)